Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2155792409', 'doi': 'https://doi.org/10.1128/aac.00842-09', 'title': 'Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers', 'display_name': 'Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers', 'publication_year': 2010, 'publication_date': '2010-01-01', 'ids': {'openalex': 'https://openalex.org/W2155792409', 'doi': 'https://doi.org/10.1128/aac.00842-09', 'mag': '2155792409', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19884365', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/2798521'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1128/aac.00842-09', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S47215897', 'display_name': 'Antimicrobial Agents and Chemotherapy', 'issn_l': '0066-4804', 'issn': ['0066-4804', '1070-6283', '1098-6596'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320263', 'host_organization_name': 'American Society for Microbiology', 'host_organization_lineage': ['https://openalex.org/P4310320263'], 'host_organization_lineage_names': ['American Society for Microbiology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://europepmc.org/articles/pmc2798521?pdf=render', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5048162351', 'display_name': 'Sherene Min', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}, {'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Sherene Min', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}, {'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064337611', 'display_name': 'Ivy Song', 'orcid': 'https://orcid.org/0000-0002-6624-4791'}, 'institutions': [{'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}, {'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Ivy Song', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I4210114143', 'https://openalex.org/I1309191912']}, {'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043729176', 'display_name': 'Julie Borland', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}, {'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Julie Borland', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}, {'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100751117', 'display_name': 'Shuguang Chen', 'orcid': 'https://orcid.org/0000-0003-4464-7968'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Shuguang Chen', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}, {'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058472962', 'display_name': 'Yu Lou', 'orcid': 'https://orcid.org/0009-0007-1343-6064'}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}, {'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Yu Lou', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}, {'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041385302', 'display_name': 'Tamio Fujiwara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}, {'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}], 'countries': ['JP', 'US'], 'is_corresponding': False, 'raw_author_name': 'Tamio Fujiwara', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina,', 'Infectious Diseases MDC, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709.', 'Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}, {'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina,', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}, {'raw_affiliation_string': 'Infectious Diseases MDC, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709.', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5063738784', 'display_name': 'Stephen C. Piscitelli', 'orcid': 'https://orcid.org/0000-0002-4528-3273'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}, {'id': 'https://openalex.org/I4210114143', 'display_name': 'GlaxoSmithKline (United States)', 'ror': 'https://ror.org/025vn3989', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I188950975', 'https://openalex.org/I4210114143']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP', 'US'], 'is_corresponding': True, 'raw_author_name': 'Stephen C. Piscitelli', 'raw_affiliation_strings': ['GlaxoSmithKline, Research Triangle Park, North Carolina', 'and Shionogi & Co., Ltd., Osaka, Japan'], 'affiliations': [{'raw_affiliation_string': 'GlaxoSmithKline, Research Triangle Park, North Carolina', 'institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143']}, {'raw_affiliation_string': 'and Shionogi & Co., Ltd., Osaka, Japan', 'institution_ids': ['https://openalex.org/I4210118477']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5063738784'], 'corresponding_institution_ids': ['https://openalex.org/I1309191912', 'https://openalex.org/I4210114143', 'https://openalex.org/I4210118477'], 'apc_list': None, 'apc_paid': None, 'fwci': 11.73, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 228, 'citation_normalized_percentile': {'value': 0.999901, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '54', 'issue': '1', 'first_page': '254', 'last_page': '258'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'Efficacy and Safety of Antiretroviral Therapy for HIV', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome', 'score': 0.9977, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12369', 'display_name': 'Epidemiology and Pathogenesis of Pneumocystis Pneumonia', 'score': 0.9961, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.77495253}, {'id': 'https://openalex.org/keywords/integrase-inhibitors', 'display_name': 'Integrase Inhibitors', 'score': 0.521381}, {'id': 'https://openalex.org/keywords/integrase-inhibitor', 'display_name': 'Integrase inhibitor', 'score': 0.5078495}, {'id': 'https://openalex.org/keywords/elvitegravir', 'display_name': 'Elvitegravir', 'score': 0.488449}, {'id': 'https://openalex.org/keywords/cmin', 'display_name': 'Cmin', 'score': 0.44430858}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.43391144}], 'concepts': [{'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.87299085}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.77495253}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.69674635}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6317494}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.59351426}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.59108233}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.5276172}, {'id': 'https://openalex.org/C2777302000', 'wikidata': 'https://www.wikidata.org/wiki/Q412251', 'display_name': 'Integrase inhibitor', 'level': 5, 'score': 0.5078495}, {'id': 'https://openalex.org/C2777068322', 'wikidata': 'https://www.wikidata.org/wiki/Q2740966', 'display_name': 'Elvitegravir', 'level': 5, 'score': 0.488449}, {'id': 'https://openalex.org/C76318530', 'wikidata': 'https://www.wikidata.org/wiki/Q16833590', 'display_name': 'Area under the curve', 'level': 2, 'score': 0.44865343}, {'id': 'https://openalex.org/C2778335254', 'wikidata': 'https://www.wikidata.org/wiki/Q5137314', 'display_name': 'Cmin', 'level': 4, 'score': 0.44430858}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.43391144}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35019565}, {'id': 'https://openalex.org/C22979827', 'wikidata': 'https://www.wikidata.org/wiki/Q5137311', 'display_name': 'Cmax', 'level': 3, 'score': 0.3387608}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.23198903}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.12517792}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.09535545}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.08101392}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D019428', 'descriptor_name': 'HIV Integrase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006261', 'descriptor_name': 'Headache', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D006261', 'descriptor_name': 'Headache', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D006575', 'descriptor_name': 'Heterocyclic Compounds, 3-Ring', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010078', 'descriptor_name': 'Oxazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011728', 'descriptor_name': 'Pyridones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012894', 'descriptor_name': 'Sleep Stages', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D012894', 'descriptor_name': 'Sleep Stages', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1128/aac.00842-09', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S47215897', 'display_name': 'Antimicrobial Agents and Chemotherapy', 'issn_l': '0066-4804', 'issn': ['0066-4804', '1070-6283', '1098-6596'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320263', 'host_organization_name': 'American Society for Microbiology', 'host_organization_lineage': ['https://openalex.org/P4310320263'], 'host_organization_lineage_names': ['American Society for Microbiology'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2798521', 'pdf_url': 'https://europepmc.org/articles/pmc2798521?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798521', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19884365', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2798521', 'pdf_url': 'https://europepmc.org/articles/pmc2798521?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 8, 'referenced_works': ['https://openalex.org/W2007831756', 'https://openalex.org/W2024158612', 'https://openalex.org/W2053125329', 'https://openalex.org/W2059566597', 'https://openalex.org/W2087400133', 'https://openalex.org/W2109360985', 'https://openalex.org/W2150504993', 'https://openalex.org/W2311992111'], 'related_works': ['https://openalex.org/W2994691634', 'https://openalex.org/W2889529422', 'https://openalex.org/W2736858899', 'https://openalex.org/W2605669224', 'https://openalex.org/W2493982696', 'https://openalex.org/W2467304892', 'https://openalex.org/W2134795055', 'https://openalex.org/W2054172655', 'https://openalex.org/W1994342377', 'https://openalex.org/W1489859663'], 'abstract_inverted_index': {'ABSTRACT': [0], 'S/GSK1349572': [1, 48, 141, 282], 'is': [2], 'a': [3, 152, 191, 224, 238, 259], 'novel': [4], 'integrase': [5, 23], 'inhibitor': [6], 'with': [7, 119, 123, 151, 258], 'potent': [8], 'in': [9, 14, 79, 203], 'vitro': [10, 15], 'anti-HIV': [11], 'activity,': [12], 'an': [13, 80], 'resistance': [16], 'profile': [17, 299], 'different': [18], 'from': [19, 210], 'those': [20], 'of': [21, 47, 58, 70, 90, 102, 200, 214, 250], 'other': [22], 'inhibitors,': [24], 'and': [25, 29, 36, 45, 76, 105, 133, 197, 218, 232], 'favorable': [26], 'preclinical': [27], 'safety': [28], 'pharmacokinetics': [30], '(PK).': [31], 'Randomized,': [32], 'double-blind,': [33], 'placebo-controlled': [34], 'single-dose': [35, 54], 'multiple-dose,': [37], 'dose': [38, 226, 261], 'escalation': [39], 'studies': [40], 'evaluated': [41], 'the': [42, 53, 85, 124, 159, 177, 187, 201, 248, 251, 269], 'PK,': [43], 'safety,': [44], 'tolerability': [46], 'for': [49, 110], 'healthy': [50], 'subjects.': [51], 'In': [52, 84], 'study,': [55, 87], 'two': [56], 'cohorts': [57, 89], '10': [59, 91, 111], 'subjects': [60, 92], 'each': [61, 93], '(8': [62, 94], 'active,': [63, 95], '2': [64, 96], 'receiving': [65, 97], 'placebo)': [66, 98], 'received': [67, 99], 'suspension': [68, 100], 'doses': [69, 101, 305], '2,': [71], '5,': [72], '10,': [73, 103], '25,': [74, 104], '50,': [75], '100': [77], 'mg': [78, 107], 'alternating': [81], 'panel': [82], 'design.': [83], 'multiple-dose': [86], 'three': [88], '50': [106], 'once': [108], 'daily': [109], 'days.': [112], 'A': [113], 'cytochrome': [114], 'P450': [115], '3A': [116], '(CYP3A)': [117], 'substudy': [118], 'midazolam': [120, 287], 'was': [121, 142, 158, 174, 262, 278], 'conducted': [122], '25-mg': [125], 'dose.': [126], 'Laboratory': [127], 'testing,': [128], 'vital': [129], 'signs,': [130], 'electrocardiograms': [131], '(ECGs),': [132], 'PK': [134, 173, 298], 'sampling': [135], 'were': [136, 149, 171], 'performed': [137], 'at': [138, 223, 237, 247], 'regular': [139], 'intervals.': [140], 'well': [143], 'tolerated.': [144], 'Most': [145], 'adverse': [146], 'events': [147], '(AEs)': [148], 'mild,': [150], 'few': [153], 'moderate': [154], 'AEs': [155], 'reported.': [156], 'Headache': [157], 'most': [160], 'common': [161], 'AE.': [162], 'No': [163], 'clinically': [164], 'significant': [165], 'laboratory': [166], 'trends': [167], 'or': [168], 'ECG': [169], 'changes': [170], 'noted.': [172], 'linear': [175], 'over': [176, 190], 'dosage': [178], 'range': [179], 'studied.': [180], 'The': [181, 242, 276, 297], 'steady-state': [182, 245], 'geometric': [183, 243], 'mean': [184, 244], 'area': [185], 'under': [186], 'concentration-time': [188], 'curve': [189], 'dosing': [192, 252], 'interval': [193, 253], '(AUC': [194], '0-τ': [195], ')': [196, 208, 257], 'maximum': [198], 'concentration': [199, 246, 273], 'drug': [202], 'plasma': [204], '(': [205, 254], 'C': [206, 255], 'max': [207], 'ranged': [209], '16.7': [211], 'μg·h/ml': [212, 229], '(coefficient': [213], 'variation': [215], '[CV],': [216], '15%)': [217, 236], '1.5': [219], 'μg/ml': [220, 234], '(CV,': [221, 230, 235], '24%)': [222], '10-mg': [225], 'to': [227], '76.8': [228], '19%)': [231], '6.2': [233], '50-mg': [239, 260], 'dose,': [240], 'respectively.': [241], 'end': [249], 'τ': [256], '1.6': [263], 'μg/ml,': [264], 'approximately': [265, 279], '25-fold': [266], 'higher': [267], 'than': [268], 'protein-adjusted': [270], '90%': [271], 'inhibitory': [272], '(0.064': [274], 'μg/ml).': [275], 'half-life': [277], '15': [280], 'h.': [281], 'had': [283], 'no': [284], 'impact': [285], 'on': [286], 'exposure,': [288], 'indicating': [289], 'that': [290, 301], 'it': [291], 'does': [292], 'not': [293], 'modulate': [294], 'CYP3A': [295], 'activity.': [296], 'suggests': [300], 'once-daily,': [302], 'low': [303], 'milligram': [304], 'will': [306], 'achieve': [307], 'therapeutic': [308], 'concentrations.': [309]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2155792409', 'counts_by_year': [{'year': 2024, 'cited_by_count': 8}, {'year': 2023, 'cited_by_count': 9}, {'year': 2022, 'cited_by_count': 15}, {'year': 2021, 'cited_by_count': 11}, {'year': 2020, 'cited_by_count': 13}, {'year': 2019, 'cited_by_count': 14}, {'year': 2018, 'cited_by_count': 17}, {'year': 2017, 'cited_by_count': 5}, {'year': 2016, 'cited_by_count': 17}, {'year': 2015, 'cited_by_count': 21}, {'year': 2014, 'cited_by_count': 26}, {'year': 2013, 'cited_by_count': 26}, {'year': 2012, 'cited_by_count': 23}], 'updated_date': '2024-09-13T23:07:32.737750', 'created_date': '2016-06-24'}